MAR 25, 202657 MINS READ
Polyglycolic acid tube is constructed from polyglycolide, a linear aliphatic polyester synthesized primarily through ring-opening polymerization of glycolide monomers 1. The polymer chain consists of repeating glycolic acid ester linkages (-OCH₂CO-), forming a highly crystalline structure with a melting point ranging from 215°C to 225°C for homopolymers 1. The crystallinity of PGA typically exceeds 45-55%, contributing to its superior mechanical properties and dimensional stability 2.
The molecular architecture of PGA tubes can be tailored through copolymerization strategies. Incorporation of lactide, ε-caprolactone, or trimethylene carbonate as comonomers enables modulation of degradation kinetics and mechanical flexibility 3. For tissue engineering scaffolds, poly(lactide-co-glycolide) (PLGA) copolymers with PGA:PLA ratios of 85:15 to 99:1 are commonly employed to balance structural integrity with controlled degradation rates 3. The weight-average molecular weight (Mw) of PGA suitable for tube fabrication typically ranges from 50,000 to 200,000 Da, with polydispersity indices (Mw/Mn) between 1.5 and 3.0 19.
Melt viscosity constitutes a critical processing parameter for PGA tube extrusion. High-quality tubes require PGA resins exhibiting melt viscosities of 200-2,000 Pa·s at 270°C and shear rates of 120 sec⁻¹ 413. Lower viscosity grades (20-500 Pa·s at melting point +20°C, 100 sec⁻¹ shear rate) are preferred for compression molding and solution casting applications 7. The residual glycolide monomer content must be maintained below 0.5 wt% to achieve optimal tensile strength exceeding 750 MPa and knot strength above 600 MPa in filament-based tube constructs 11.
Solidification and extrusion molding represents the predominant industrial method for producing PGA tubes with diameters exceeding 100 mm 413. The process involves melting PGA resin at 240-280°C, extruding through annular dies, and applying controlled back pressure during solidification to suppress radial expansion 1320. Critical process parameters include:
The resulting extruded tubes exhibit densities of 1.575-1.625 g/cm³ and can be manufactured with wall thicknesses from 5 mm to 100 mm 20. For larger diameter tubes (100-500 mm) intended for petroleum ball sealer applications, post-extrusion compression and controlled drawing are essential to reduce residual stress and improve machinability 13.
For biomedical tissue engineering applications, tubular PGA constructs are fabricated by wrapping non-woven PGA fiber sheets around gas-permeable silicone mandrels 2. The manufacturing sequence comprises:
This approach produces tubular scaffolds with uniform PGA density throughout the construct, critical for consistent cell seeding and tissue ingrowth in vascular grafts and tracheal replacements 2.
Advanced PGA tube designs incorporate multilayer structures combining PGA barrier layers with thermoplastic polyester (PET) or other resins to optimize gas impermeability and mechanical durability 16. Co-injection stretch blow molding enables fabrication of containers where PGA intermediate layers (10-30 μm thickness) are embedded between inner and outer PET layers 16. The process involves:
These multilayer tubes demonstrate oxygen transmission rates below 0.05 cc/(m²·day·atm) and withstand hot-filling at 93°C for 20 seconds without delamination 16.
High-molecular-weight PGA tubes exhibit exceptional mechanical performance. Monofilament tubes produced via optimized melt-spinning and stretching protocols achieve:
The tensile modulus of PGA composites can be enhanced through addition of calcium-containing inorganic compounds (calcium carbonate, hydroxide, or phosphate) at 5-20 wt%, achieving moduli exceeding 5,800 MPa while maintaining thermal stability 1519. However, excessive filler loading (>25 wt%) may accelerate hydrolytic degradation and reduce ductility 19.
PGA tubes demonstrate thermal stability up to 200°C under inert atmospheres, with onset of thermal degradation occurring at 220-240°C 1. Key thermal properties include:
Melt stability during processing is enhanced by incorporating carboxyl end-blocking agents (e.g., epoxy compounds at 0.1-1.0 wt%) and heat stabilizers (hindered phenols, phosphites) to suppress chain scission and discoloration 15. Optimized formulations maintain yellowness index below 5 and weight-average molecular weight retention >90% after multiple extrusion cycles 5.
PGA tubes undergo bulk erosion through random hydrolytic cleavage of ester bonds, with degradation rates dependent on:
In physiological conditions (37°C, pH 7.4), PGA homopolymer tubes lose 50% of initial tensile strength within 2-4 weeks and achieve complete mass loss in 4-6 months 38. PLGA copolymers with higher lactide content (e.g., 85:15 PGA:PLA) extend degradation timelines to 6-12 months, suitable for long-term tissue scaffolds 3. Surface treatment with 1M NaOH increases degradation rate by 30-50% through enhanced water penetration 2.
Tubular PGA scaffolds serve as foundational constructs for growing decellularized extracellular matrix (ECM) vascular grafts 2. The fabrication process involves:
The resulting tissue-engineered vascular grafts (TEVGs) demonstrate burst pressures exceeding 2,000 mmHg, suture retention strengths >200 g, and patency rates >80% in preclinical large animal models over 6-month implantation periods 2. Attachment of non-biodegradable polyethylene terephthalate (PET) supports at tube ends facilitates surgical anastomosis and prevents end-fraying during handling 2.
PGA monofilament and braided tubes constitute the gold standard for absorbable surgical sutures since their introduction in the 1970s 89. Key performance specifications include:
PGA sutures are colored green using 0.03-0.5 wt% 1,4-bis(p-toluidino)-anthraquinone (D&C Green No. 6) to enhance visibility against tissue and blood 14. Storage stability is ensured through packaging in air-tight, water vapor-impermeable laminate films (aluminum foil/polyethylene) with internal atmospheres containing <0.05 wt% moisture and inert gases (nitrogen, argon) 12. Under these conditions, sutures maintain >90% of initial tensile strength for ≥12 months at 22°C storage 12.
Solid PGA tubes are machined into biodegradable orthopedic implants including:
These devices provide initial fixation strengths of 200-400 N (shear) and 150-300 N (pull-out), sufficient for early-stage healing 8. Degradation proceeds over 6-12 months, with gradual load transfer to regenerating bone tissue 8. Incorporation of calcium phosphate fillers (10-30 wt%) enhances osteoconductivity and buffers acidic degradation products 15.
Tubular PGA constructs enable controlled release of therapeutic agents through:
For example, PGA tubes loaded with bone morphogenetic protein-2 (BMP-2) at 0.5-2.0 mg/mL demonstrate sustained release over 4-8 weeks, promoting ectopic bone formation in rat models 8. Similarly, antibiotic-loaded PGA tubes (gentamicin 5-10 wt%) provide local infection prophylaxis in contaminated surgical sites 8.
PGA tubes with diameters of 100-500 mm are machined into ball sealers for temporary zonal isolation during multi-stage hydraulic fracturing operations 413. Manufacturing specifications include:
The extrusion process for ball sealer stock involves:
PGA ball sealers offer advantages over conventional dissolvable alloys (magnesium, aluminum) including lower material costs ($50-100 per ball vs. $200-500), reduced environmental impact, and compatibility with high-salinity brines 4.
PGA tubes serve as biodegradable mandrels for composite liner installation and temporary plugs for well intervention operations 13. Typical dimensions
| Org | Application Scenarios | Product/Project | Technical Outcomes |
|---|---|---|---|
| Humacyte | Vascular graft replacement for patients requiring small-diameter blood vessel substitutes, particularly in cardiovascular and peripheral vascular surgical applications. | Tissue-Engineered Vascular Grafts (TEVG) | Tubular PGA scaffolds with seam density 50-70 mg/cc enable uniform cell seeding and ECM deposition, achieving burst pressures exceeding 2,000 mmHg and patency rates >80% over 6-month implantation. |
| Kureha Corporation | Multi-stage hydraulic fracturing operations in petroleum wells requiring temporary zonal isolation, particularly in high-temperature downhole environments. | PGA Ball Sealers for Hydraulic Fracturing | Extrusion-molded PGA tubes with melt viscosity 200-2,000 Pa·s at 270°C achieve compressive strength >80 MPa and complete downhole degradation within 7-30 days at 60-120°C, eliminating need for mechanical retrieval. |
| Kureha Corporation | Absorbable surgical sutures for wound closure in general surgery, orthopedic procedures, and soft tissue repair requiring high initial strength and predictable degradation. | High-Strength PGA Monofilament Sutures | Optimized melt-spinning process with residual monomer <0.5 wt% produces filaments achieving tensile strength 750-900 MPa and knot strength 600-750 MPa with complete absorption in 90-120 days. |
| American Cyanamid Company | Orthopedic fixation devices for fracture repair, ACL reconstruction, and meniscal repair requiring biodegradable implants with gradual load transfer to healing tissue. | PGA Prosthetic Devices | Solid PGA constructs provide surgically useful mechanical properties as reinforcing pins, screws, and plates that are absorbed and replaced by living tissue over 4-6 months, eliminating need for removal surgery. |
| Kureha Corporation | Food and beverage packaging applications requiring superior gas barrier properties and heat resistance for hot-filling processes while maintaining transparency and durability. | Multilayer PGA Barrier Containers | Co-injection stretch blow molding embeds 10-30 μm PGA intermediate layers between PET layers, achieving oxygen transmission rates <0.05 cc/(m²·day·atm) and hot-fill resistance at 93°C for 20 seconds. |